Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
The American Society of Clinical Oncology has warned against intravenous infusion of chemotherapy and monoclonal antibodies in cancer patients’...
News from the FDA/CDC
The unique clinical features in the U.S. case are urinary retention secondary to dysautonomia and ocular symptoms of...
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
Two variants of Guillain-Barré syndrome—Miller Fisher syndrome and polyneuritis cranialis—have been linked with COVID-19 infection.
From the Journals
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...